ILMN — ILLUMINA, INC.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1110803 ·
Last close
$202.61
Market Cap
$30.59B
52W High
$309.35
52W Low
$112.65
ADV30
2,229,679
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 1,091,000,000 | 721,000,000 | 209,000,000 | 134,000,000 | 6,559,000,000 | 1,089,000,000 | 3,883,000,000 |
| Dec 2025 | 1,159,000,000 | 759,000,000 | 211,000,000 | 334,000,000 | 6,644,000,000 | 1,418,000,000 | 3,921,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,128,000,000
Investing CF
$-358,000,000
Financing CF
$-800,000,000
CapEx
$-161,000,000
Dividends Paid
—
Buybacks
$-784,000,000
EPS Diluted TTM
$5.81
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-258,000,000
Inventory
$611,000,000
Receivables
$738,000,000
ST Investments
$66,000,000
EBIT TTM
$1,160,000,000
Pretax Income TTM
$1,060,000,000
Interest Exp TTM
$100,000,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,538,999,808
EBITDA
$1,226,000,000
Free Cash Flow
$997,500,032
Enterprise Value
$36,525,490,176
Total Cash
$1,336,999,936
Total Debt
$2,228,000,000
Shares Out
151,000,000
Trailing EPS
$5.36
Book Value
$18.80
ROE
32.4%
ROA
9.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,343,000,000 | 817,000,000 | 850,000,000 | 6,644,000,000 | 3,921,000,000 | 2,723,000,000 | 1,079,000,000 |
| Dec 2024 | 4,372,000,000 | 600,000,000 | -1,223,000,000 | 6,303,000,000 | 3,930,000,000 | 2,373,000,000 | 837,000,000 |
| Dec 2023 | 4,504,000,000 | -222,000,000 | -1,161,000,000 | 10,111,000,000 | 4,366,000,000 | 5,745,000,000 | 478,000,000 |
| Dec 2022 | 4,584,000,000 | 354,000,000 | -4,404,000,000 | 12,252,000,000 | 5,653,000,000 | 6,599,000,000 | 392,000,000 |
TTM Snapshot
Revenues TTM
$4,493,000,000
NetIncome TTM
$825,000,000
OpCashFlow TTM
—
Assets (Latest)
$6,650,000,000
Forward EPS
$6.13
Max Pain — expiry 2026-12-18
max pain strike: $210.00 · spot: $210.01 · call oi: 4,019 · put oi: 2,210
Expected Move to 2026-12-18:
±$28.10
(13.38%) —
implied range
$181.91 –
$238.11
· ATM straddle on $210.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KBGGY | Kongsberg Gruppen ASA/ADR | $30.72B | $17.46 | — |
| DISPF | Disco Corporation/ADR | $30.41B | $280.38 | — |
| RSHGY | RESONA HOLDINGS INC | $30.11B | $26.96 | — |
| CKHGF | Capitec Limited/ADR | $31.74B | $274.02 | — |
| CQP | Cheniere Energy Partners, L.P. | $29.35B | $60.64 | — |
News headlines (Yahoo Finance, 1h cache)
Genomic Data Set for RWE Applications - Global Strategic Business Report 2026: Capitalize on 16% CAGR and $1.5B in Total Revenue by 2032 with Illumina, Caris Life Sciences and Datavant
2026-11-18 15:38 · Yahoo
Illumina Stock Outlook: Is Wall Street Bullish or Bearish?
2026-11-18 10:33 · Yahoo
Illumina Sees Strong Clinical Demand, but Research Recovery Remains in Question
2026-11-17 14:13 · Yahoo
Illumina (ILMN) Stock Sees Modest Fair Value Lift As Analysts Debate Growth Outlook
2026-11-13 05:13 · Yahoo
Is Illumina Stock Worth The Wait?
2026-11-11 15:29 · Yahoo
Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher an
2026-11-11 14:44 · Yahoo
Carrier Screening - Global Strategic Business Report 2026: Secure Your Share of a $7.6 Billion Market by 2032 | Features Competitive Intelligence on Illumina, Natera, BGI Genomics, and Myriad Genetics
2026-11-11 14:25 · Yahoo
Whole Exome Sequencing - Global Strategic Business Report 2026: Capitalize on 19.5% CAGR to $2.3 Billion by 2032 as Illumina, Thermo Fisher Scientific, BGI Genomics, and QIAGEN Accelerate
2026-11-11 14:20 · Yahoo
Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032
2026-11-11 14:18 · Yahoo
Human Identification - Global Strategic Business Report 2026: Capitalize on 10.1% CAGR to $1.9 Billion by 2032 | Thermo Fisher, Illumina, Qiagen and Bio-Rad Vie for Shares
2026-11-11 14:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.